Albemarle to sell antioxidant, ibuprofen and propofol businesses to SI Group
Albemarle announced an agreement to sell certain assets to SI Group, a leading global developer and manufacturer of chemical intermediates, specialty resins, and solutions. Included are Albemarle's antioxidants and FDA-regulated ibuprofen and propofol businesses and assets. April 16, 2014